Insulin Price Savings: Half Off Diabetes Costs
Half off insulin and diabetes supplies through Telegram deal groups
Over 37 million Americans live with diabetes, and the cost of insulin and diabetes supplies has been a national crisis for years. While recent legislation has capped insulin costs at $35 per month for Medicare beneficiaries and many commercial plans, many patients still pay far more than they should due to gaps in coverage, high-deductible plans, or lack of awareness about available assistance programs. The Insulin Price Savings group on Telegram is dedicated to helping every diabetes patient in America access affordable insulin and supplies.
The $35 Insulin Cap: What You Need to Know
The Inflation Reduction Act capped insulin copays at $35 per month for Medicare Part D beneficiaries starting in 2023, and many major insulin manufacturers — Eli Lilly, Novo Nordisk, and Sanofi — have voluntarily extended $35 caps to commercial and uninsured patients through their own programs. However, the cap only applies to the insulin itself and doesn't automatically cover supplies like syringes, test strips, or continuous glucose monitors. The Telegram group shares detailed information about how to ensure the $35 cap is correctly applied at your pharmacy and how to access additional savings for diabetes supplies beyond insulin.
Members share tips for navigating the specific rules of each manufacturer's cap program, including which insulin types are covered, how to enroll, and what to do if your pharmacy doesn't automatically apply the cap. The group also tracks state-level insulin price cap legislation and shares information about which states have the strongest protections for diabetes patients.
Manufacturer Programs from Lilly, Novo Nordisk and Sanofi
Each of the three major insulin manufacturers offers assistance programs that go beyond the $35 cap. Eli Lilly's Lilly Cares program provides free insulin to qualifying patients. Novo Nordisk's PAP offers free insulin and supplies to patients without insurance or with high copays. Sanofi's Insulin Savings Program provides $35 per month insulin to commercially insured patients. The group maintains updated information about each program's eligibility requirements, application processes, and member success rates.
Members share tips for maximizing manufacturer assistance, including how to apply to multiple programs simultaneously, how to use manufacturer coupons with insurance to achieve the lowest possible cost, and how to request emergency supplies when you're between applications. The group also shares information about manufacturer patient advocacy programs that can help navigate coverage issues and appeal denials.
State Assistance Programs
Many states offer additional diabetes assistance programs that can supplement federal protections and manufacturer programs. These include state pharmaceutical assistance programs, Medicaid expansion coverage for diabetes supplies, and state-funded programs that provide free or reduced-cost diabetes care. The group maintains a state-by-state database of available programs, including eligibility requirements and application links. Members share their experiences applying to these programs and tips for navigating each state's specific requirements.
Walmart ReliOn Insulin
Walmart's ReliOn brand insulin is available without a prescription in many states and costs $25-$73 per vial — significantly less than brand-name insulin at retail prices. The group shares information about ReliOn insulin availability in different states, the specific types available (regular, NPH, and analog), and tips for discussing ReliOn insulin with your healthcare provider. While ReliOn insulin is an older formulation, it's safe and effective for many patients, and the cost savings can be dramatic compared to brand-name alternatives.
CGM and Diabetes Supply Savings
Continuous Glucose Monitors (CGMs) like Dexcom and FreeStyle Libre have transformed diabetes management but can cost $300-$500 per month without insurance. The group shares strategies for getting CGMs covered by insurance, manufacturer assistance programs that reduce or eliminate CGM costs, and tips for qualifying for CGM coverage even when insurance initially denies it. Members also share savings on other diabetes supplies like test strips, lancets, and insulin pump supplies, including which brands offer the best value and which manufacturer programs provide supplies at no cost.
Available in These Cities
Frequently Asked Questions
The $35 cap applies to Medicare Part D plans and many commercial insurance plans. Eli Lilly, Novo Nordisk, and Sanofi have also extended $35 caps to uninsured patients through their own programs. Our group provides a checklist for determining which cap applies to your specific plan and steps to take if your pharmacy isn't correctly applying the cap. If you're uninsured, we walk you through enrolling in the manufacturer's direct cap program.
Walmart ReliOn insulin is FDA-approved and meets the same safety and efficacy standards as brand-name insulin. It uses older insulin formulations (regular and NPH) that have been used safely for decades. While newer analog insulins offer more flexibility in dosing timing, many patients do well on ReliOn insulin. Our group shares member experiences and tips for discussing the switch with your healthcare provider.
Coverage for CGMs depends on your insurance plan and whether you meet specific clinical criteria, such as using insulin multiple times daily or having frequent hypoglycemia. Our group provides documentation templates that your doctor can use to support a CGM coverage request, and tips for appealing denials. We also share manufacturer programs that provide CGMs at reduced cost or free for qualifying patients.